The Steering Committee (SC) has elected an Executive Board to take over the management of the German Biobank Node (GBN) from 1 February 2024. PD Dr. Sara Nußbeck was elected as spokesperson and “National Node Director” – as GBN representative to the European biobank network BBMRI-ERIC. Nußbeck’s deputies on the Executive Board are Dr. Gabriele Anton and PD Dr. Dr. Michael Kiehntopf. Their term of office will be two years.
The election was the first of its kind, with Prof. Dr. Michael Hummel leading the GBN since its inception ten years ago. Hummel will remain on the SC as a strategic advisor during a transition period.
After taking over from Hummel, the new Executive Board will continue to develop the overall strategy of the GBN and the German Biobank Alliance (GBA) in cooperation with the SC. Other future tasks of the Executive Board will be
- supervision of the work of the GBN office and the activities of the network,
- representation of GBN/the GBA at events,
- liaising closely with funding bodies on national and European developments and with other relevant stakeholders
- as well as close cooperation – especially of the National Node Director – with BBMRI-ERIC.
With Sara Nußbeck, Gabriele Anton and Michael Kiehntopf, three proven biobanking experts and experienced networkers are available for these tasks.